CoreAge Rx vs YOURx Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and YOURx Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 61 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make YOURx Health a bad call — it's best for people comparing injectable and tablet formats who can verify the actual prescription, clinician, renewal amount and pharmacy fulfillment stage. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | YOURx Health |
|---|---|---|
| Brief Score | 94/100 (A) | 61/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $159/mo injection; new-patient offer Tablet $139/mo for new patients. Injection pages include consultation, supplies, shipping and support. Preparation, quantity, renewal and tablet-fee scope unconfirmed; Mississippi excluded. Stop subscriptions before next billing and prescription orders before pharmacy fulfillment. Delivered prescriptions nonreturnable; report damage/wrong medication/dispensing errors within 30 days for review. Full price detailsSemaglutide injection and rapid-dissolve tablet offered; preparation and complete selected-prescription quote unknown; new-patient injection $159/month and tablet $139/month displayed, renewal and full supplied quantity unconfirmed |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $179/mo injection; new-patient offer Tablet $159/mo for new patients. Injection pages include consultation, supplies, shipping and support. Preparation, quantity, renewal and tablet-fee scope unconfirmed; Mississippi excluded. Stop subscriptions before next billing and prescription orders before pharmacy fulfillment. Delivered prescriptions nonreturnable; report damage/wrong medication/dispensing errors within 30 days for review. Full price detailsTirzepatide injection and rapid-dissolve tablet offered; preparation and complete selected-prescription quote unknown; new-patient injection $179/month and tablet $159/month displayed, renewal and full supplied quantity unconfirmed |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ says service in all states except Mississippi; selected clinician and pharmacy eligibility still require confirmation |
| Brand-name access | Not confirmed | Current catalog ingredient and format names do not establish a branded GLP-1 product; confirm the exact preparation with the prescriber and pharmacy. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
YOURx Health: New-patient injections $159 semaglutide/$179 tirzepatide; tablets $139/$159. Full supply and renewal unconfirmed; Mississippi excluded. Cancel before billing and pharmacy fulfillment; report delivery errors within 30 days.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.